Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results

Jorge E. Cortes, Delphine Rea, Michael J. Mauro, Andreas Hochhaus, Dong-Wook Kim, Koji Sasaki, Fabian Lang, Michael C. Heinrich, Massimo Breccia, Michael Deininger, Yeow-Tee Goh, Jeroen J. W. M. Janssen, Moshe Talpaz, Valle Gómez García de Soria, Philipp le Coutre, Francois-Xavier Mahon, Daniel J. DeAngelo, Andrea Damon, Shruti Kapoor, Gessami Sanchez-Olle, Matthias Hoch, Nithya Agrawal, Sara Quenet, Timothy P. Hughes

Open source

DOI: 10.1038/s41375-026-02972-9
Published: 2026-07-16
Container: Leukemia
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41375-026-02972-9,
  title = {Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results},
  author = {Jorge E. Cortes and Delphine Rea and Michael J. Mauro and Andreas Hochhaus and Dong-Wook Kim and Koji Sasaki and Fabian Lang and Michael C. Heinrich and Massimo Breccia and Michael Deininger and Yeow-Tee Goh and Jeroen J. W. M. Janssen and Moshe Talpaz and Valle Gómez García de Soria and Philipp le Coutre and Francois-Xavier Mahon and Daniel J. DeAngelo and Andrea Damon and Shruti Kapoor and Gessami Sanchez-Olle and Matthias Hoch and Nithya Agrawal and Sara Quenet and Timothy P. Hughes},
  year = {2026},
  journal = {Leukemia},
  doi = {10.1038/s41375-026-02972-9},
  url = {https://doi.org/10.1038/s41375-026-02972-9}
}

RIS

TY  - JOUR
TI  - Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results
AU  - Jorge E. Cortes
AU  - Delphine Rea
AU  - Michael J. Mauro
AU  - Andreas Hochhaus
AU  - Dong-Wook Kim
AU  - Koji Sasaki
AU  - Fabian Lang
AU  - Michael C. Heinrich
AU  - Massimo Breccia
AU  - Michael Deininger
AU  - Yeow-Tee Goh
AU  - Jeroen J. W. M. Janssen
AU  - Moshe Talpaz
AU  - Valle Gómez García de Soria
AU  - Philipp le Coutre
AU  - Francois-Xavier Mahon
AU  - Daniel J. DeAngelo
AU  - Andrea Damon
AU  - Shruti Kapoor
AU  - Gessami Sanchez-Olle
AU  - Matthias Hoch
AU  - Nithya Agrawal
AU  - Sara Quenet
AU  - Timothy P. Hughes
PY  - 2026
JO  - Leukemia
DO  - 10.1038/s41375-026-02972-9
UR  - https://doi.org/10.1038/s41375-026-02972-9
ER  -

APA

Cortes, J. E., Rea, D., Mauro, M. J., Hochhaus, A., Kim, D., Sasaki, K., Lang, F., Heinrich, M. C., Breccia, M., Deininger, M., Goh, Y., Janssen, J. J. W. M., Talpaz, M., Soria, V. G. G. D., Coutre, P. L., Mahon, F., DeAngelo, D. J., Damon, A., Kapoor, S., Sanchez-Olle, G., Hoch, M., Agrawal, N., Quenet, S., & Hughes, T. P. (2026). Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results. Leukemia. https://doi.org/10.1038/s41375-026-02972-9

Source records

crossref · retrieved 2026-09-25T12:52:18.146Z